BRAIN.Q

Country:
Israel
Founding year:
2016

BrainQ Technologies is a neurotechnology company developing precision neuromodulation platforms designed to support rehabilitation following neurological damage. The company focuses on restoring motor and functional outcomes by targeting neural networks involved in recovery and plasticity.

BrainQ’s system combines EEG-based brain mapping with artificial intelligence to generate personalized electromagnetic stimulation protocols. These protocols are delivered non-invasively and are designed to selectively activate neural circuits associated with motor control and rehabilitation, rather than applying generic stimulation patterns.

BrainQ’s technology is intended for clinical rehabilitation settings, particularly for patients recovering from stroke or other central nervous system injuries. The company positions its platform as a data-driven neuromodulation approach that augments standard neurorehabilitation by accelerating and enhancing recovery processes.

Neuromodulation
Therapeutics
Closed-loop

Neurofounders Insights

Modality:
TMS
Form Factor:
Software/app
Interface Depth:
Non-invasive
Indication:
Stroke
Target user:
Clinicians
Regulatory stage:
CE-Marked

Series B

BRAIN.Q is differentiated by its AI-personalized electromagnetic field therapy approach to post-stroke recovery, where stimulation parameters are tailored to individual neural network patterns rather than delivered at fixed protocols. With CE marking, Phase 2 data showing a threefold improvement in functional independence, and Series B funding, it sits among the more clinically advanced non-invasive stroke-recovery platforms.

Related companies

Articles featuring

BRAIN.Q

No articles yet!

Press releases

No press releases published yet.